cetuximab

Ukraine

Drugs containing this active substance

  • ERBITUX

    The drug is used to treat metastatic colorectal cancer (provided certain genetic markers are present, such as wild-type RAS genes and EGFR expression) and squamous cell carcinoma of the head and neck (in combination with radiotherapy or chemotherapy, or as monotherapy).

    Form: solution for infusion

    Active substance Dosage
    cetuximab 5 mg/ml

    ATC: L01FE01

    Manufacturer: Merck Healthcare KGaA (manufacturing of finished medicinal product, primary and secondary packaging, labeling, quality control and batch release)